Challenging MDR-TB clinical problems – The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs
Open Access
- 1 March 2019
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 80, S68-S72
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyondPulmonology, 2018
- Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre studyEuropean Respiratory Journal, 2017
- De-isolation of patients with pulmonary tuberculosis after start of treatment — clear, unequivocal guidelines are missingInternational Journal of Infectious Diseases, 2017
- Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challengesEuropean Respiratory Journal, 2016
- First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquilineEuropean Respiratory Journal, 2016
- WHO strategies for the programmatic management of drug-resistant tuberculosisExpert Review of Respiratory Medicine, 2016
- Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB ConsiliumInternational Journal of Infectious Diseases, 2015
- ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid useEuropean Respiratory Journal, 2014
- Taddeo Alderotti e le radici medioevali della terapia steroideaL'Endocrinologo, 2014
- Supporting TB clinicians managing difficult cases: the ERS/WHO ConsiliumEuropean Respiratory Journal, 2013